EMvision Medical Devices (ASX:EMV) Dividends Received: A$0.00 Mil (TTM As of Dec. 2025)


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
31 GF Score
Price A$1.51
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Dividends Received?

EMvision Medical Devices ASX:EMV +0.67% 31 Dividends Received is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's Dividends Received for the six months ended in Dec. 2025 was A$0.00 Mil.

EMvision Medical Devices's Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

EMvision Medical Devices Dividends Received Related Terms

EMvision Medical Devices Dividends Received Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Dividends Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Dividends Received Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends Received
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:EMV
31GF Score
EMvision Medical Devices Ltd ASX:EMV
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Dividends Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.

Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Received →
What does a Dividends Received of A$0.00 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Dividends Received of A$0.00 Mil as of Dec. 2025. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for EMvision Medical Devices and its competitors.
Is EMvision Medical Devices' Dividends Received too high?
EMvision Medical Devices' current Dividends Received is A$0.00 Mil. Overall, EMvision Medical Devices has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Dividends Received compare to ABT and SYK?
EMvision Medical Devices' Dividends Received of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Medical Devices & Instruments company?
A good Dividends Received depends on the Medical Devices & Instruments industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for EMvision Medical Devices and its competitors. EMvision Medical Devices's current Dividends Received is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Dividends Received of A$0.00 Mil. The current Dividends Received is A$0.00 Mil. EMvision Medical Devices' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Dividends Received is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
31GF Score

Get the complete analysis for ASX:EMV

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.51
Price